Our Interactive calculator demonstrates the healthcare and work-loss costs to your organization due to opiod abuse


Annual Healthcare Cost To Employer (Abuser)


Excess Healthcare Cost of an Abuser vs Non-Abuser


Annual In-direct Work-Loss Costs


**Calculations are based upon the national average of abusers per 10,000 employees. Update Source: Analysis Group, Inc, (pg. 441)

Start Saving Today!

Call Us to Learn More (888) 603-8181

Personalized Medication


How We Help Self-Insured Employers and Unions

Opiate Epidemic In The U.S.

The latest from the Newsroom

Experience the advantage of excellent service, solutions, partnership, integrity and innovation with a leading multi-specialty health care company like Advanced Therapeutics. 

Another outbreak related to the nation’s opioid crisis: hepatitis C

 The nation’s opioid epidemic has unleashed a secondary outbreak: the rampant spread of hepatitis C.

New cases of the liver disease have nearly tripled nationwide in just a few years, driven largely by the use of needles among drug users in their 20s and 30s, spawning a new generation of hepatitis C patients. Because a treatment that cures the disease costs tens of thousands of dollars, is limited by insurance and Medicaid, and is mostly unavailable to people who are still using illicit drugs, there probably will be financial and public health ramifications for decades to come.

Here in West Virginia, which has the nation’s highest rates of overdose deaths and new hepatitis C and hepatitis B infections, public-health officials are attempting to identify as many new hepatitis carriers as possible — and are girding for decades of repercussions.

Article Link

Read More

Former DEA agent: Congress, drug industry hindered opioid crackdown

A former employee of the Drug Enforcement Administration (DEA) said in a new interview on Sunday that efforts to stem the growing opioid epidemic in the U.S. were derailed by pressure from large pharmaceutical companies and Congress.

Joe Rannazzisi told CBS’s “60 Minutes” that major distributors, including Cardinal Health, McKesson and AmerisourceBergen, allowed drugs to be obtained by rogue pharmacies and pain clinics, which then prescribed them to Americans “who had no legitimate need for those drugs.”

Article Link

Read More